Investors need to pay close attention to Galera (GRTX) stock based on the movements in the options market lately.
By Sam Boughedda
The FDA bestows an Orphan Drug designation to Coherus (CHRS) and partner Junshi's toripalimab for the treatment of esophageal cancer.